http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-35441-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F126-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F26-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F20-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F32-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
filingDate 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da666f8ffe8d3696f561df5c8ccd1283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e65113a571ed12defc06aab0fd60d23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d81a1781f72e2ce8008aefac2b1b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fc14cbfbf0c5131f05c03485205defe
publicationDate 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-35441-A
titleOfInvention CHEMICAL AGENTS OF PRECURSORS OF ADVANCED GLICATION FINAL PRODUCT (AGE).
abstract AGE precursor chelating agents comprise amines separated by 2, 3 or 4 carbons. AGE precursor chelating agents can be used as pharmaceutical agents and in pharmaceutical compositions. AGE precursor chelating agents are particularly useful binding AGE precursors and dietary dicarbonyls in mammals in the gastrointestinal tract for the treatment of diseases such as diabetic nephropathy, chronic kidney disease, atherosclerosis, stroke, cataracts, and Alzheimer's disease.
priorityDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547

Total number of triples: 29.